Suely M. Rezende

Researcher
Faculdade de Medicina, Universidade Federal de Minas Gerais, Minas Gerais, Brazil

Presentation(s):

• PB0177 - Detection of IgG4 anti-FVIII levels as complementary test to define the ITI outcome in patients with hemophilia A: results from the BrazIT Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0178 - High plasma levels of IgG4 anti-FVIII is the hallmark of immune tolerance failure in patients with hereditary hemophilia A: results from the BrazIT Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0195 - Prevalence of Sporadic Haemophilia A: an updated analysis of two cohort studies

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0201 - Pathogenic variants in F8 gene - Results from the Brazilian Immune Tolerance (BrazIT) Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0655 - Minor surgical procedures and the outcome of immunotolerance induction: an analysis of the BrazIT Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0678 - Changing Recombinant Factor VIII for Plasma-derived FVIII during Immune Tolerance Induction: Results from the Brazilian Immune Tolerance (BrazIT) Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0934 - Khorana score as a predictor of thrombotic risk in outpatients with malignant neoplasms

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1023 - Hemostasis in Yellow Fever: results from the 2018 outbreak in Brazil

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1146 - Determinants of successful immune tolerance induction in persons with hemophilia A – systematic review and meta-analysis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• VPB1341 - Mortality associated with venous thrombosis in Brazil: evidence of inequalities between low/middle- and high-income countries

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM